Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin doesn't stop hair loss.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The new "differential stripping" method effectively measures how much substance gets into hair follicles.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Lipedematous scalp is mainly caused by an increase in fat tissue under the skin and is different from lipedematous alopecia.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

In vivo confocal scanning laser microscopy is an effective, non-invasive way to study and measure new hair growth after skin injury in mice.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

AR gene not major factor in female hair loss; different from male hair loss.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

The document concludes that more research is needed to fully understand the causes of PCOS.

New treatments for PCOS focus on managing symptoms and improving fertility.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.